J Korean Med Assoc Search


J Korean Med Assoc > Volume 53(6); 2010 > Article
Journal of the Korean Medical Association 2010;53(6):524-530.
DOI: https://doi.org/10.5124/jkma.2010.53.6.524   
The Pharmacotherapy of Inflammatory Bowel Disease in Child and Adolescence
Kyung Mo Kim
Department of Pediatrics, University of Ulsan College of Medicine, Asan Medical Center Children's Hospital, Korea. kmkim@amc.seoul.kr
The importance of pediatric inflammatory bowel disease (IBD) has grown significantly, for the incidence of pediatric inflammatory bowel disease in Korea has been rapidly increasing in recent years. One quarter of the new IBD patients has been known to be presented in childhood. Growth and pubertal delay are one of key factors in the management of pediatric IBD. The focus of treatment in children should be to reduce or eliminate symptoms, optimize nutritional status and growth, and prevent complications. This review will deal with the evidence supporting the treatments currently used in children with inflammatory bowel disease.
Key Words: Inflammatory bowel disease, Crohn disease, Ulcerative colitis, Treatment


Browse all articles >

Editorial Office
Samgu B/D 7F, 40 Cheongpa-ro, Youngsan-gu, Seoul 04373, Korea
Tel: +82-1566-2844    Fax: +82-2-792-5208    E-mail: jkmamaster@kma.org                

Copyright © 2021 by Korean Medical Association.

Developed in M2PI

Close layer
prev next